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Background: Epidemiological studies have found that particulate matter is associated with increases in blood
pressure. Yet, less is known about the effects of specific sources or constituents of particulate matter, such as diesel
particulate matter or polycyclic aromatic hydrocarbons (PAHs). We evaluated associations between self-reported
hypertension and residential air levels of diesel particulate matter and PAHs among individuals of Mexican origin
living in a large inner city.
Methods: The Mano a Mano cohort (established in 2001 by the University of Texas MD Anderson Cancer Center) is
comprised of individuals of Mexican origin residing in Houston, Texas. Using geographical information systems, we
linked modeled annual estimates of PAHs and diesel particulate matter at the census tract level from the 2002 and
2005 U.S. Environmental Protection Agency’s National-Scale Air Toxics Assessment to baseline residential addresses
of cohort members who enrolled from 2001 to 2003 or 2004 to 2006, respectively. For each enrollment period, we
applied mixed-effects logistic regression models to determine associations between diesel particulate matter and
PAHs, separately, and self-reported hypertension while adjusting for confounders and the clustering of observations
within census tracts and households.
Results: The study population consisted of 11218 participants of which 77 % were women. The mean participant
age at baseline was 41 years. Following adjustment for age, there was a dose-dependent, positive association between
PAHs and hypertension (medium exposure, adjusted odds ratio (OR) = 1.09, 95 % CI: 0.88-1.36; high exposure,
OR = 1.40, 95 % CI: 1.01-1.94) for individuals enrolled during 2001–2003; associations were generally similar in
magnitude, but less precise, following adjustment for age, gender, smoking, and BMI. No association was detected for
the later period. There was no evidence of an association between residential levels of diesel particulate matter and
hypertension.
Conclusions: This study builds on a limited number of prior investigations of the association between ambient air
levels of PAHs or diesel particulate matter and hypertension by focusing on a relatively young cohort of predominantly
adult women of Mexican origin. Future analyses are warranted to explore associations in the cohort using incident
hypertension when sufficient data become available and to further examine associations between specific chemical
constituents of particulate matter and hypertension in this and other populations.
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A major risk factor for cardiovascular disease (CVD),
the leading cause of death among Hispanics [1] and
worldwide [2], is hypertension. Research has shown that
elevations of 10 mmHg diastolic blood pressure (BP)
and 5 mmHg systolic BP are associated with substantial
(as large as 50 %) increases in risks for CVD [3]. Hyper-
tension is known as a “silent killer” because most people
do not have symptoms, yet consequences can be deadly
as Hispanics experience difficulty in managing hyperten-
sion that may be due, in part, to access to medical care
or not having health insurance [4, 5].
Ambient particulate matter (PM) ranks highly among
causes of death worldwide (13th), taking the lives of
about 800,000 individuals per year [3]. An elevation of
10 μg/m3 of fine particulate matter (particulate matter
2.5 microns or less in aerodynamic diameter) can increase
BP by up to 5 mmHg [6], increasing risk for CVD, over
time, by up to 76 % [3]. Specifically, PM can increase an
individual’s BP by initiating inflammation and oxidative
stress in the lungs and then causing vasoconstriction and
endothelial damage. However, epidemiological studies
have been equivocal. Some have demonstrated that PM
exposure increases BP [3, 6-20], while a few researchers
have shown an inverse or no association [3, 21-25]. This
inconsistency suggests the need for research on specific
sources of PM such as diesel particulate matter (DPM) or
specific components of PM such as polycyclic aromatic
hydrocarbons (PAHs).
Diesel particulate matter is a likely carcinogen [26]
that is formed from combustion of diesel fuel. Similar to
PM, numerous mechanisms have been suggested to
explain how DPM exposure leads to elevated BP, such as
systemic and pulmonary inflammation, an increase of pro-
inflammatory cytokines, and oxidative stress that can im-
pair endothelial function [27-32]. PAHs are a group of
organic compounds (7 are known carcinogens) [33] and a
component of PM formed as byproducts of incomplete
combustion from sources such as fossil fuels and biomass.
They can significantly contribute to increases in BP [34].
The biological mechanisms through which PAHs exert
their effects on BP are similar to DPM, such as oxidative
stress, local inflammatory effects, endothelial damage, and
plaque promotion [35-43].
This cross-sectional investigation aimed to evaluate
the association between exposures to residential air
levels of PAHs and DPM and hypertension among a




We used data collected from the Mexican American
Cohort Study (MACS), also known as the “Mano a Mano”cohort study that was established by the Department of
Epidemiology at the University of Texas MD Anderson
Cancer Center (UTMDACC) in 2001. The Mano a Mano
cohort is comprised of individuals of Mexican origin who
at enrollment resided in Houston, TX for at least 1 year.
Recruitment methods included random-digit dialing and
block walking. All adult participants signed an informed
consent and completed a baseline interview to seek infor-
mation about their demographics, medical history, degree
of acculturation, lifestyle habits, and work history. In this
study, we restricted our analyses to a subset of the entire
cohort, comprised of adults aged 18 years and older who
enrolled during the period of 2001–2006 (N = 11218). In-
dividuals from the same household were eligible to partici-
pate. Most households (5147) had one member, 2645
households had two members, 184 households had three
members, 56 households had four members, and one
household had five members. Our study was approved by
The University of Texas Health Science Center, Commit-
tee for Protection of Human Subjects and by the MD
Anderson Cancer Center Institutional Review Board.
Outcome assessment
All participants were interviewed in person to determine
their medical history including hypertension status. In
the current study, we considered that a participant was
hypertensive if they answered yes to the question: “have
you been told by a health professional that you have
high blood pressure or hypertension?”.
Exposure assessment
Modeled estimates of ambient air levels of PAHs and
DPM were extracted from the 2002 and 2005 National-
Scale Air Toxics Assessment (NATA) developed by the
U.S. Environmental Protection Agency (EPA) [44]. NATA
provides information on more than 180 toxic air pollut-
ants (181 in 2002 and 187 in 2005) based primarily on
emissions from point sources, non-point sources, mobile
sources, background sources, and sources from secondary
formation (i.e., the transformation of one pollutant to an-
other pollutant) in specific geographic areas [45, 46]. To
generate the nationwide estimates of ambient air levels of
toxic air pollutants (reported in units of μg/m3), depend-
ing on the source of emissions, NATA uses the National
Emissions Inventory or the National Mobile Inventory
Model (NMIM) to input data into two models, the As-
sessment System for Population Exposure Nationwide
(ASPEN) and the Human Exposure Model 3 (HEM-3),
respectively. In NATA, 16 PAHs are included among
the broad classification of compounds termed Polycyc-
lic Organic Matter (PAHPOM) [44].
Table 1 shows a breakdown of DPM and PAH mod-
eled concentrations in percentiles. For analyses, we con-
verted μg/m3 of PAHs to ng/m3. Using geographic
Table 1 Residential air levels for diesel particulate matter (DPM)




5 25 50 75 95
DPM
2001–2003 2.44 3.58 4.82 10.66 25.32
2004–2006 1.18 1.71 2.53 3.80 7.28
PAHs
2001–2003 1.79 2.16 2.48 3.77 7.20
2004–2006 1.26 1.42 1.63 1.92 2.62
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CA)), the geocoded residences of participants who en-
rolled during 2001 to 2003 or 2004 to 2006 were linked to
the 2002 or 2005 data, respectively.Potential confounders
Information that was collected during the baseline inter-
view included: date of birth, gender, comorbid condi-
tions (previous diagnosis of diabetes, heart attack/
disease, or high cholesterol), smoking status (current,
former, and never), alcohol use (current, former, and
never), body mass index (BMI) based on self-reported
height and weight, educational attainment (bachelor de-
gree and higher, high school graduate or GED, some
high school, and no formal schooling or elementary or
middle school), nativity status (U.S. born or Mexican
born), length of residence at baseline address (<1 year, 1
to 5 years, > 5 years), number of years living in the U.S.,
physical activity (“active” if a participant engaged in
strenuous exercise ≥ 1.5 h/week or moderate exercise ≥
3 h/week; otherwise, “not active”), current employment
status (currently working or currently not working), and
degree of acculturation based on the Bidimensional Ac-
culturation Scale for Hispanics (BAS) (high, BAS > 2.50
and low, BAS ≤ 2.50) [47].Statistical analysis
In preliminary analyses, we generated frequency distribu-
tions of socio-demographic and lifestyle factors among
our study population. We performed chi-squared analyses
to evaluate differences in categorical risk factors between
enrollment periods, as well as simple logistic regression
analyses to evaluate crude associations between covariates
and hypertension status at a significance level of 0.05. We
used multilevel mixed-effects logistic regression models to
examine associations between PAHs or DPM and hyper-
tension status. Air pollutant concentrations were modeled
as both continuous and categorical variables, the latter
based on the following categorization scheme: <50th,
50-89th, ≥90th percentiles. We included random effectsfor census tract and household to account for corre-
lated observations as individuals were nested within
households and households were nested within census
tracts. To assess for confounding, we applied multiple
logistic regression models to determine associations be-
tween DPM and PAHs and hypertension while adjusting
for the covariates listed above (see section on “Potential
Confounders”), one at a time. Covariates were retained in
the final model if their inclusion resulted in ≥ 10 % change
in the estimate of the odds ratio [48].
Additionally, we compared associations for partici-
pants who lived at their baseline address for less than or
equal to five years and for those that have lived at their
baseline address for greater than five years because we
expected less misclassification of exposure among indi-
viduals who lived at their residence for the longer time
period. We also conducted a sensitivity analysis based
on employment status at baseline because our exposure
assessment that relied on residential location may have
resulted in a different error structure for individuals who
did not work outside of the home as compared to those
who did. All statistical analyses were conducted using
Intercooled STATA, version 11 (StataCorp LP, College
Station, TX).
Results
The study population consisted of 11218 participants
from 8033 households enrolled between 2001 and 2006.
In total, 13.1 % and 16.7 % of the cohort who enrolled in
2001–2003 or 2004–2006, respectively, reported having
hypertension. Across both time periods, approximately
77 % of study participants were women and more than
50 % of participants were between 25 and 44 years of
age. The mean age at baseline was 41 years. Most partic-
ipants did not possess a high school degree (about 60 %)
and approximately 60 % were currently employed.
Table 2 provides a breakdown of the distribution of co-
variates for participants by hypertension status for each
enrollment period. Except for age and degree of accultur-
ation (as assessed by the BAS score), there were differ-
ences (p < 0.05) for all other selected covariates. Notably,
the proportion of women who enrolled in the cohort was
greater in 2004–2006 (82 %) as compared to 2001–2003
(72 %) and 73 % of cohort members were currently
employed in the earlier time period while only 48 % were
currently employed in the later time period.
In simple logistic regression analyses (see Table 2),
odds of prevalent hypertension increased with age, years
living at the baseline address, and BMI. Increased odds
of hypertension were also detected among persons with
diagnoses of high cholesterol, a prior heart attack, or
diabetes, as well as those who were physically inactive.
We detected higher odds for hypertension among U.S.
born individuals as compared to those born in Mexico;
Table 2 Distribution of characteristics for participants and crude associations with hypertension status by enrollment period (N = 1121
Characteristic 2001–2003 2004–2006
Hypertension OR 95 CI Hypertensio OR 95 CI
No Yes No Yes
Gender**
Men 1237 156 Ref Ref 943 207 Ref Ref
Women 3053 489 1.32* 1.07 - 1.62 4294 839 0.9 0.74 - 1.09
Age
18–34 2021 31 Ref Ref 2445 97 Ref Ref
35–54 1680 240 9.60* 6.52 - 14.14 2142 419 5.42* 4.20 - 6.99
55–74 589 374 45.39* 29.78 - 69.17 650 530 26.37* 18.87 - 36.86
Level of education**
Middle School or less 1523 371 2.78* 2.12 - 3.64 1780 574 2.77* 2.13 - 3.60
Some High School/High School Graduate/GED 1743 172 1.00 0.76 - 1.33 2571 349 0.97 0.75 - 1.25
More than High School 1024 102 Ref Ref 882 122 Ref Ref
Missing 0 0 NA NA 4 1 NA NA
Currently employed**
No 233 24 0.64 0.41 - 1.00 2282 496 1.20* 1.02 - 1.42
Yes 3097 493 Ref Ref 2563 475 Ref Ref
Missing 960 128 NA NA 392 75 NA NA
Years living at baseline address**
<1 668 54 Ref Ref 1009 108 Ref Ref
1–5 1718 146 1.07 0.75 - 1.52 2249 326 1.39* 1.07 - 1.81
>5 1902 445 3.23* 2.32 - 4.49 1979 612 3.32* 2.56 - 4.31
Missing 2 0 NA NA 0 0 NA NA
High cholesterol diagnosis**
Yes 273 171 6.41* 4.86 -8.43 528 364 6.88* 5.35 - 8.86
No 4017 474 Ref Ref 4709 682 Ref Ref
Heart attack diagnosis**
Yes 15 12 5.92* 2.41 - 14.53 19 36 14.72* 7.15 - 30.31
No 4275 633 Ref Ref 5218 1010 Ref Ref
Diabetes diagnosis**
Yes 365 241 6.89* 5.49 - 8.66 470 385 7.74* 6.09 - 9.84












Table 2 Distribution of characteristics for participants and crude associations with hypertension status by enrollment period (N = 11218) (Continued)
Smoking status**
Current 630 75 0.82 0.62 - 1.09 637 115 0.94 0.73 - 1.21
Former 565 155 2.03* 1.61 - 2.57 667 194 1.57* 1.27 - 1.94
Never 2916 415 Ref Ref 3897 737 Ref Ref
Missing 179 0 NA NA 36 0 NA NA
Alcohol use**
Current 1157 113 0.58 0.46 - 0.74 1204 182 0.71 0.57 - 0.87
Former 431 129 1.97* 1.53 - 2.54 430 164 2.16* 1.68 - 2.77
Never 2524 403 Ref Ref 3487 698 Ref Ref
Missing 178 0 NA NA 116 2 NA NA
Physical activity level**
Active 1160 110 Ref Ref 1209 176 Ref Ref
Not active 3099 530 1.91* 1.50 - 2.41 4002 864 1.58* 1.29 - 1.94
Missing 31 5 NA NA 26 6 NA NA
BMI (kg/m2)**
Underweight/Normal (<24.9) 1020 82 Ref Ref 1180 102 Ref Ref
Overweight (25.0–29.9) 1559 187 1.55* 1.16 - 2.09 1798 331 2.40* 1.83 - 3.16
Obese I-III (≥30.0) 1674 375 3.13* 2.36 - 4.15 2115 588 3.96* 3.02 - 5.20
Missing 37 1 NA NA 144 25 NA NA
Degree of acculturation
High level of acculturation (BAS > 2.50) 1583 219 0.83 0.68 - 1.01 1903 377 0.95 0.80 - 1.12
Low level of acculturation (BAS ≤ 2.50) 2699 426 Ref Ref 3317 665 Ref Ref
Missing 8 0 NA NA 17 4 NA NA
No. of years living in the U.S.**
≤9 1207 63 Ref Ref 1613 158 Ref Ref
10–14 614 42 1.34 0.88 - 2.03 845 96 1.18 0.88 - 1.59
≥15 2469 540 4.54* 3.39 - 6.08 2778 792 3.34* 2.68 - 4.15
Missing 0 0 NA NA 1 0 NA NA
Nativity**
U.S. born 1288 255 1.52* 1.26 - 1.84 1347 368 1.66* 1.39 - 1.97
Mexico born 3001 390 Ref Ref 3874 676 Ref Ref
Other 1 0 NA NA 16 2 NA NA
Abbreviations: CI confidence interval, OR odds ratio, NA not applicable
*p < 0.05 for associations between covariates and hypertension status (crude odds ratio)
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the U.S. Women experienced higher odds of hyperten-
sion as compared to men enrolled in 2001-2003, but not
in 2004-2006.
Age at baseline was the only variable identified as a
confounder for the association between DPM and hyper-
tension. Gender, smoking, and BMI, risk factors of hyper-
tension were then added to the model to determine if
joint confounding was evident. Results indicated less than
a 10 % difference in the odds ratios when comparing the
results for the age-adjusted model to the fully adjusted
model. Nonetheless, for completeness, we present the
fully-adjusted results along with prevalence odds ratios
(ORs) and 95 % Confidence Intervals (CIs) for the associ-
ation between hypertension and DPM adjusted only for
the random effects (census tracts and households) and age
at baseline in Table 3.
For the 2001-2003 enrollment period with only random
effects included in the model, the odds of hypertension
were elevated for DPM in the medium and high exposure
groups when compared to the referent category (OR =
1.31, 95 % CI: 1.07-1.61; OR = 1.13, 95 % CI: 0.81-1.58).
Following additional adjustment for age at baseline, odds
ratios (medium exposure category: OR = 1.15, 95 % CI:
0.92-1.42; high exposure category: OR = 1.10, 95 % CI:
0.77-1.57) diminished somewhat in magnitude and results
were less precise. For the 2004-2006 enrollment period,
we observed odds ratios of 1.29 (95 % CI: 1.04-1.61) and
1.14 (95 % CI = 0.80-1.62) for the medium and high expos-
ure groups, respectively. Following adjustment for age, the
ORs were close to the null (medium: OR = 1.03; 95 %
CI = 0.85-1.25; high: OR = 0.92; 95 % CI = 0.67 - 1.27).
For both enrollment periods, associations were generally
similar in magnitude, but less precise, following adjust-
ment for age, gender, smoking, and BMI. No associationsTable 3 Odds Ratios (95 % CIs) for the associations between hypert
Enrollment period DPMa N OR b
2001–2003 Referent (1.39 – 4.81) 2450 —
Medium (4.82 – 17.69) 1987498 1.31*
High (17.70 – 25.32) 1.13
Continuous (per μg/m3) 1.01
2004–2006 Referent (0.75 – 2.52) 2874 —
Medium (2.53 – 5.82) 2735 1.29*
High (5.83 – 8.77) 674 1.14
Continuous (per μg/m3) 1.03
Abbreviations: CI confidence interval, OR odds ratio
*Significant at p < 0.05
aReferent: < 50th percentile, Medium: 50-89th percentile, High: ≥ 90th percentile
bAdjusted for census tract and household as random effects
cAdjusted for age at baseline and census tract and household as random effects
dAdjusted for age at baseline, gender, smoking, and BMI and census tract and housin any of the models were detected when DPM was mod-
eled as a continuous variable.
Similar to DPM, age at baseline was the only variable
identified as a confounder for PAHs. Gender, smoking,
and BMI were also added to this model, but similarly to
DPM, there was little evidence of joint confounding. Re-
sults for PAHs are reported in Table 4. Following adjust-
ment for the random effects for census tracts and
households, we observed elevated odds for hypertension
in the medium (OR = 1.09; 95 % CI: 0.89-1.34) and high
(OR = 1.56; 95 % CI = 1.16-2.11) exposure groups for
those members enrolled in the earlier (2001–2003) en-
rollment period (Table 4). Following additional adjust-
ment for age at baseline, odds ratios remained elevated
for both exposure groups (OR = 1.09; 95 % CI = 0.88-
1.36 for the medium exposure group and OR = 1.40;
95 % CI: 1.01-1.94 for the high exposure group). After
adjusting for age, gender, smoking, and BMI, associa-
tions were similar in magnitude, albeit less precise.
Additionally, for the 2001-2003 enrollment period in
the age-adjusted model, the odds for hypertension also
increased by 5 % (OR = 1.05, 95 % CI: 1.00-1.12) for a
one unit increase (ng/m3) in ambient PAH levels. For
the 2004-2006 enrollment group, no associations be-
tween PAHs and hypertension were detected.
For the 2001-2003 enrollment group living more than
5 years at their baseline address, age-adjusted odds ra-
tios were elevated for the medium (OR = 1.12, 95 % CI:
0.86 - 1.47) and high (OR = 1.33, 95 % CI: 0.90 - 1.97) ex-
posure groups. For persons living five years or less at their
baseline address, age-adjusted odds ratios were 1.05 (95 %
CI: 0.72 - 1.54) and 1.68 (95 % CI: 0.93 - 1.13) for the
medium and high exposed groups, respectively. For per-
sons who did not work outside of the home, odds ratios
were elevated but extremely imprecise due to smallension and diesel particulate matter (DPM) (μg/m3)
95 % CI ORc 95 % CI ORd 95 % CI
— — — — —
1.07 – 1.61 1.15 0.92 – 1.42 1.13 0.91 – 1.41
0.81 – 1.58 1.10 0.77 – 1.57 1.01 0.71 – 1.45
0.99 – 1.03 1.01 0.99 – 1.02 1.00 0.99 – 1.02
— — — — —
1.04 – 1.61 1.03 0.85 – 1.25 1.05 0.86 – 1.29
0.80 – 1.62 0.92 0.67 – 1.27 0.84 0.61 – 1.17
0.98 – 1.10 0.99 0.94 – 1.04 0.98 0.93 – 1.03
ehold as random effects
Table 4 Odds Ratios (95 % CIs) for the associations between hypertension and polycyclic aromatic hydrocarbons (PAHs) (ng/m3)
Enrollment period PAHsa N ORb 95 % CI ORc 95 % CI ORd 95 % CI
2001–2003 Referent (0.92 – 2.47) 2338 — — — — — —
Medium (2.48 – 4.76) 2083 1.09 0.89 – 1.34 1.09 0.88 – 1.36 1.07 0.85 – 1.33
High (4.77 – 12.38) 514 1.56* 1.16 – 2.11 1.40* 1.01 – 1.94 1.32 0.95 – 1.83
Continuous (per ng/m3) 1.07* 1.02 – 1.13 1.05* 1.00 – 1.12 1.04 0.98 – 1.10
2004–2006 Referent (0.91 – 1.62) 3112 — — — — — —
Medium (1.63 – 2.30) 2511 0.96 0.78 – 1.19 0.90 0.74 – 1.09 0.87 0.72 – 1.06
High (2.31 – 12.76) 660 0.79 0.56 – 1.11 0.96 0.71 – 1.31 0.97 0.71 – 1.33
Continuous (per ng/m3) 1.01 0.91 – 1.12 0.99 0.90 – 1.08 0.99 0.90 – 1.09
Abbreviations: CI confidence interval, OR odds ratio
*Significant at p < 0.05
aReferent: < 50th percentile, Medium: 50-89th percentile, High: ≥ 90th percentile
bAdjusted for census tract and household as random effects
cAdjusted for age at baseline and census tract and household as random effects
dAdjusted for age at baseline, gender, smoking, and BMI and census tract and household as random effects
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hence the results are not shown.
Discussion
While epidemiological studies have found that particulate
matter is associated with increases in blood pressure, less
is known about the effects of specific sources or constitu-
ents of PM, such as diesel particulate matter or polycyclic
aromatic hydrocarbons. In our cross-sectional evaluation
of the associations between hypertension and residential
air levels of DPM and PAHs among individuals of
Mexican-origin, our results indicate an association be-
tween PAHs and hypertension for individuals enrolled
in the 2001-2003 time period, but not in the later time
period. There were little to modest differences in the
associations when the cohort was stratified on the basis
of how long participants lived at their current addresses
at baseline. No associations were detected for DPM in
either time period.
Our positive findings for an association between PAHs
and hypertension agree with the panel study by Jacobs
et al. [49], who concluded that chrysene-5,6-dione and
benzo[a]pyrene-3,6-dione can increase systolic BP and
pulse pressure. In addition, animal studies have demon-
strated that arterial BP can increase due to exposure to a
PAH-contained organic mixture derived from coal [50],
as well as to specific PAHs, benzo[a]pyrene (BaP), and
dimethylbenz[a]anthracene (DMBA) [36, 51, 52]. An-
other study, however, showed a lack of association be-
tween PAHs and BP in rats [53], but was criticized for
its BaP administration and BP monitoring methods [36].
Contrary to the positive associations reported in Cosselman
et al. [54] and Nemmar et al. [30], our results did not
provide evidence for an association between DPM and
hypertension for individuals in either enrollment
period. However, our findings are similar to the four
previous randomized, double-blind, cross-over studiesconducted on DPM and cardiopulmonary effects that
concluded that DPM had no significant effect on BP
[28, 29, 55, 56].
We observed a dose-dependent association between
PAHs and hypertension among individuals enrolled in
the 2001-2003 time period, but no association for indi-
viduals who enrolled in the 2004-2006 period. Differ-
ences in characteristics of the study population between
enrollment periods may explain the equivocal findings.
There were more women enrolled in the cohort in
2004-2006 (who appear to have a more modest associ-
ation between PAHs and hypertension than men - see
discussion below) as compared to 2001-2003, and a
significantly greater proportion of participants were cur-
rently employed in the earlier time period than in the later
time period. Secondly, there were differences in the distri-
butions of PAH modeled concentrations by time period
(the interquartile range for PAHs in 2002 was 1.61 ng/m3
as compared to 0.5 ng/m3 in 2005) that may also explain
the equivocal findings. While such differences may be due
to the change in methodology that NATA used to gener-
ate the two data releases, a decline in emissions or both
[45, 46], decreased levels of variability in the 2005
NATA data likely diminished the comparisons that
could be made between exposure groups.
Based on the results from our sensitivity analyses be-
tween those who lived at their residential address for five
or more years as compared to those who lived at their
address for less than 5 years, there appeared to be a
modest increase in the odds ratio for the longer-term
residents when comparing the high exposure group (but
not the middle exposure group) to the low exposure
group. Results from previous studies that evaluated asso-
ciations between PM exposures and CVD outcomes pro-
duced equivocal results, with some studies reporting
little differences based on length of residence whereas
others reported stronger associations for participants
Table 5 Associations between PAHs (ng/m3) and hypertension
by age, gender, and smoking status (2002 enrollment period)
Potential covariate PAHsa OR 95 % CI
Ageb
18-34 (n = 2052) Referent (0.92 – 2.47) —
Medium (2.48 – 4.76) 1.35 0.63 - 2.89
High (4.77– 12.38) 1.70 0.54 - 5.31
Continuous (per ng/m3) 1.05 0.87 - 1.27
35-54 (n = 1920) Referent (0.92 – 2.47) —
Medium (2.48 – 4.76) 1.01 0.74 - 1.40
High (4.77 – 12.38) 1.45 0.91 - 2.33
Continuous (per ng/m3) 1.06 0.98 - 1.15
55-74 (n = 963) Referent (0.92 – 2.47) —
Medium (2.48 – 4.76) 1.09 0.81 - 1.47
High (4.77 – 12.38) 1.30 0.84 - 2.02
Continuous (per ng/m3) 1.05 0.97 - 1.14
Genderc
Men (n = 1393) Referent (0.92 – 2.47) — —
Medium (2.48 – 4.76) 1.51 0.67 – 3.39
High (4.77 – 12.38) 2.03 0.52 – 7.97
Continuous (per ng/m3) 1.09 0.87 – 1.37
Women (n = 3542) Referent (0.92 – 2.47) — —
Medium (2.48 – 4.76) 1.06 0.80 - 1.42
High (4.77 – 12.38) 1.41 0.93 – 2.15
Continuous (per ng/m3) 1.06 0.99 – 1.14
Smokingc
Never (n = 3331) Referent (0.92 – 2.47) — —
Medium (2.48 – 4.76) 1.00 0.76 – 1.32
High (4.77 – 12.38) 1.02 0.67 – 1.56
Continuous (per ng/m3) 1.01 0.94 – 1.09
Current (n = 705) Referent (0.92 – 2.47) — —
Medium (2.48 – 4.76) 1.30 0.75 – 2.25
High (4.77 – 12.38) 1.84 0.81 – 4.18
Continuous (per ng/m3) 1.10 0.95 – 1.27
Former (n = 720) Referent (0.92 – 2.47) — —
Medium (2.48 – 4.76) 1.41 0.69 – 2.86
High (4.77 – 12.38) 4.99* 1.35 – 18.46
Continuous (per ng/m3) 1.18 0.97 – 1.44
Abbreviations: CI confidence interval, OR odds ratio
*Significant at p < 0.05
aReferent: < 50th percentile, Medium: 50-89th percentile,
High: ≥ 90th percentile
bAdjusted for census tract and household as random effects
cAdjusted for age at baseline and census tract and household as
random effects
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addresses [57, 58]. Associations between roadway traffic
noise and hypertension were also stronger for residents liv-
ing at their current addresses for more than 10 years [59].
In post-hoc analyses, we further explored the potential
for effect measure modification due to sex, smoking, and
age for the association between PAHs and hypertension
among individuals enrolled in the earlier time period
(Table 5). While we recognize that our study was under-
powered to evaluate effect modification, interesting results
emerged. Both men and women showed dose response re-
lationships between PAH exposure and hypertension sta-
tus. Differences were also detected on the basis of smoking
status, with the strongest association between hyperten-
sion and high level of PAH exposure observed among
former smokers. When evaluating potential differences by
age at enrollment, stronger associations were observed for
individuals in the youngest (18–34 years) age category.
An advantage of the current study was that it built
upon a large cohort of relatively young individuals,
mostly women, of Mexican origin who live in Houston,
TX. Also, as result of having data on cohort members
collected by interview, this study provided a substantial
amount of information on potential factors that may op-
erate as confounders. Houston is the fourth largest
metropolitan city in the U.S., is one of the busiest sea-
ports, has considerable amounts of traffic, and is home
to the largest petrochemical complex in the country.
Houstonians are exposed to more air pollutants than in-
dividuals residing in most other U.S. cities [60], and
therefore, the city of Houston was an ideal location for
this study. While inferences are limited to individuals of
Mexican origin, research has shown that Hispanics have
poorer cardiovascular profiles [60], lower socioeconomic
status, increased all-cause mortality rates, and are less
likely to have health insurance than other ethnic groups
[5]. These individuals represent a rapidly growing popu-
lation (60 % of the Hispanic population), which has re-
ceived little attention regarding health effects due to air
pollutant exposure in Houston, TX.
Limitations of this study include analyzing prevalent ra-
ther than incident disease, which calls into question the
temporal relationship between the two primary exposures
of interest (PAHs and DPM) and hypertension. As previ-
ously noted, the Mano a Mano cohort is predominantly
female and young and hence our results may not be
generalizable to males or to an older population. For our
outcome assessment, cohort members self-reported their
hypertension status. Research has been inconsistent in de-
termining whether self-reporting hypertension is an accur-
ate measure of hypertension [61-63]. We would have
preferred to use measured blood pressure, prescription
history for anti-hypertensive medications, or physicians’
reports to determine hypertension status, but such datawere not available. We cannot rule out information bias
because participants who live in neighborhoods with
poorer air quality may have been more likely to self-
report having hypertension due to living in worse built
Bangia et al. Environmental Health  (2015) 14:51 Page 9 of 11environments and exposures to myriad psychosocial
stressors. Finally, it is possible that some younger
women were reporting gestational hypertension in re-
sponse to the question about having hypertension, but the
questionnaire did not differentiate pregnancy-induced
hypertension from other types.
Generating exposure estimates from modeled rather
than monitored assessments has strengths and limita-
tions. Using data from NATA allowed us to account for
a variety of stationary and mobile sources along with
providing the ability to have specific components of PM
measured [45, 46]. However, NATA does not model in-
door exposure sources or account for individual behav-
iors and activities, which may contribute significantly to
personal exposures. Studies on comparisons between in-
door, outdoor, and personal exposures have found mixed
results [64-66]. While questions remain whether NATA
modeled estimates can appropriately act as surrogates
for personal exposures to PAHs and DPM, there are lim-
ited epidemiologic investigations assessing the influence
of outdoor air levels of PAHs and DPM on hypertension
and the use of this secondary data was a cost-effective
first approach in assessing these associations.
Conclusions
To our knowledge, this is among the first studies to
analyze the relationship between ambient levels of two
air pollutants, PAHs and DPM, and self-reported hyper-
tension among relatively young individuals, mostly
women, of Mexican origin. Our multiple logistic regres-
sion analysis suggests that ambient levels of PAHs were
associated with hypertension for the 2001-2003 enrolled
individuals and did show a dose response relationship.
No associations between ambient levels of DPM and
odds of hypertension were observed. Future analyses are
warranted to further explore associations in the Mano a
Mano cohort using incident hypertension when sufficient
data become available and to explore risks of hypertension
with specific chemical constituents (e.g., metals and or-
ganic carbon) of particulate matter.
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